Literature DB >> 10814890

Formation and persistence of O(6)-methylguanine in the mouse colon following treatment with 1,2-dimethylhydrazine as measured by an O(6)-alkylguanine-DNA alkyltransferase inactivation assay.

P E Jackson1, D P Cooper, T A Meyer, M Wood, A C Povey, G P Margison.   

Abstract

Female SWR mice were treated with 1,2-dimethylhydrazine (DMH: 6.8 mg/kg i.p. injection) once weekly for up to 10 weeks, a dosing regime that produced tumours principally within the distal colon (Jackson et al., 1999. Carcinogenesis 20, 509-513). O(6)-Methylguanine (O(6)-MeG) levels, measured using a simple [3H]-based O(6)-alkylguanine-DNA alkyltransferase (ATase) inactivation assay, ranged from 0.6 to 16.7 fmol/microg DNA with: (i) highest levels in the distal colon; and (ii) higher levels after 68 mg/kg total DMH than 6.8 mg/kg DMH. Basal ATase activity varied between 0.97 and 1.22 fmol/microg DNA within the colon but was not associated with adduct levels or tumour induction. After 6.8 mg/kg DMH, the half life of O(6)-MeG in colonic tissue was 36-42 h whereas after 68 mg/kg DMH, t1/2 was approximately 25, 57 and 96 h in the proximal, mid and distal colon, respectively. Tumour induction was thus associated with the levels and persistence of O(6)-MeG in the distal colon.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10814890     DOI: 10.1016/s0378-4274(00)00193-4

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  2 in total

1.  Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts.

Authors:  Brett L Carlson; Patrick T Grogan; Ann C Mladek; Mark A Schroeder; Gaspar J Kitange; Paul A Decker; Caterina Giannini; Wenting Wu; Karla A Ballman; C David James; Jann N Sarkaria
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-09-01       Impact factor: 7.038

2.  IGF-II transgenic mice display increased aberrant colon crypt multiplicity and tumor volume after 1,2-dimethylhydrazine treatment.

Authors:  Daniela Diehl; Doris Oesterle; Martin W Elmlinger; Andreas Hoeflich; Eckhard Wolf; Harald Lahm
Journal:  J Carcinog       Date:  2006-11-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.